Jw Holdings (096760.KS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · South Korea · ISIN KR7096760004

Price
3,705.00 KRW
Market cap
256.35 bn KRW
P/E (2025)
–
P/S (2025)
0.26
Dividend yield
5.80 %
Net margin
6.03 %
Return on equity (ROE)
9.84 %
Return on assets (ROA)
4.75 %

Jw Holdings financials

Fiscal year20242025
Revenue887.71 bn KRW969.57 bn KRW
Gross profit435.22 bn KRW491.47 bn KRW
Operating income146.77 bn KRW167.90 bn KRW
EBIT190.30 bn KRW164.11 bn KRW
Net income62.62 bn KRW58.50 bn KRW

Full history since 2007, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Jw Holdings

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair care, beauty care, and other cosmetics products; infant care system, gynecological examining table, sterilizer equipment, diagnostic imaging equipment, operating room equipment, non-PVC film, tube, and empty bag, and health supplements. In addition, the company provides integrated services for IV solution. JW Holdings Corporation was founded in 1945 and is based in Gwacheon-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.